Summary

The surgical robots market is projected to reach USD 23.7 billion by 2029 from USD 11.1 billion in 2024, at a CAGR of 16.5% during the forecast period. The surgical robots market will grow rapidly in the near future, boosted by the development of robotic technology and several other factors. Growing need for minimally invasive operations and increasing usage by robotic systems in surgery centers and hospitals are key drivers. These robots make a variety of intricate treatments easier by providing enhanced control, precision, and flexibility, therefore improving patient outcomes with lessened risk of complications and recovery time. Furthermore, with improved spending on health sector infrastructure and positive pricing trends at all levels, it accelerates the adoption of surgical robots. Again, an aging population and the mounting burden of chronic diseases have fired up the volume of surgeries across the globe. The growing volume naturally calls for surgical robots; their adoption becomes rapid as they find their place more and more in the lap of modern medical functioning.
“By offering, instruments and accessories segment is expected to have the largest market share in the surgical robots market.”
Based on offering, the instruments and accessories segment is expected to hold the largest market share in the surgical robots market. Because they are essential and used frequently in robotically assisted procedures, instruments and accessories have the largest share of the surgical robotics industry. Such custom specialist instruments, among them robotic arms, suturing devices, robotic arms, and specialist endoscopic tools, for each procedure are required and are frequently single-use items that need to be replaced or reprocessed after each surgery. Besides, these instruments are in constant demand for various treatments, from minimally invasive surgeries to others. Their position at the top comes partly from the high rate of use and repeated replacing of these accessories and partly from the development of surgical instruments that are supposed to help precision and reduce recuperation times for patients.
“By application, general surgery segment is expected to have the largest market share in the surgical robots market.”
Based on application, the general surgery segment is expected to hold the largest market share in the surgical robots market. General surgery represents the largest market for surgical robots, as versatility and wide applicability characterize this application. Such procedures do make up an extremely broad spectrum, which includes, among others, bariatric surgeries, cholecystectomies, hernia repairs, and alike. All these procedures are usually carried out and benefit immensely from the accuracy and less invasiveness and faster recovery periods offered by the robots. Rising cases of chronic diseases, patients' inclination towards less invasive procedures, and surgical centers and hospitals adopting robotic systems have accelerated the demand for robotic assistance in general surgeries, resulting in a higher utilization rate as compared to other specialized surgeries.

“By end user, hospitals & clinics segment is expected to have the largest market share in the surgical robots market.”
Based on end user, the hospitals & clinics segment accounted for the largest market share of the surgical robots market. With large patient volumes, a wide range of surgical procedures, and strong financial resources that enable them to invest in the latest robotic systems, it is hospitals and clinics that command the largest share in the surgical robotics market. Indeed, these are usually among the first institutions within any medical field that look toward innovative tools such as surgical robots to improve precision, reduce recovery time, and ensure better outcomes for patients. This is further supported by the presence of specialized personnel and infrastructure to run and maintain such sophisticated systems within hospitals and clinics. Moreover, with their focus on cutting-edge treatment, keeping themselves competitive achieves just that: keeping them abreast of change through constant investment in robotic surgery.
“By region, North American region is expected to have the largest market share in the surgical robots market.”
At present, North America holds the maximum share of the surgical robots industry for a number of key considerations. Advanced healthcare systems and large investments in medical technology characterize the region. Additionally, rapid adoption of innovative concepts is showcased. Further, growth of this industry is accelerated with the presence of key market players like Stryker and Intuitive Surgical. Quite favorable government regulations in North America, a high frequency of chronic conditions requiring surgical procedures, and strong purchasing power have all combined to give this region top market share in the surgical robots industry. Its leadership position is further maintained as it continues in its commitment to research and development, facilitating further developments.

A breakdown of the primary participants (supply-side) for the surgical robots market referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
• By Designation: C-level–20%, Director Level–35%, and Others–45%
• By Region: North America–27%, Europe–25%, Asia Pacific–30%, Latin America- 8%, Middle East & Africa-10% .
Prominent players in the surgical robots market are Intutive Surgical (US), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), Zimmer Biomet (US), Asensus Surgical (US), Siemens Healthineers (Germany), CMR Surgical (UK), Johnson & Johnson (US), Renishaw Plc (UK), Avateramedical GmbH (Germany), Brainlab AG (Germany), Think Surgical (US), Medicaroid Corporation (Japan), Globus Medical, Inc. (US), Corin Group (UK), Ecential Robotics (France), Titan Medical, Inc. (Canada), TINAVI Medical (China), Monteris (US), Microsure (Netherlands), Medical Microinstruments (US), Momentis Innovative Surgery (Israel), Distalmotion (Switzerland), Novus Arge (Turkey).
Research Coverage:
The report analyzes the surgical robots market and aims at estimating the market size and future growth potential of this market based on various segments such as offering, application, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall prefilled syringes market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
 Analysis of key drivers (increasing adoption of surgical robots, increasing funding, technological advancements, improving reimbursement), restraints (high cost), opportunities (increasing penetration of surgical robots in ASCs, Growth opportunities in emerging markets), challenges (surgical errors)
 Market Penetration: It includes extensive information on products offered by the major players in the global the surgical robots market. The report includes various segments in offering, application, end user and region.
 Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global surgical robots market.
 Market Development: Thorough knowledge and analysis of the profitable rising markets by offering, application, end user and region.
 Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the global the surgical robots market.
 Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the global surgical robots market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 MARKET SCOPE 30
1.3.1 MARKETS COVERED 30
1.3.2 INCLUSIONS & EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 31
1.3.4 CURRENCY CONSIDERED 31
1.4 STAKEHOLDERS 32
1.5 SUMMARY OF CHANGES 32
1.6 CURRENT TRENDS 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
2.1.2.1 Key data from primary sources 38
2.1.2.2 Key industry insights 39
2.2 MARKET SIZE ESTIMATION 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 46
2.4 MARKET SHARE ESTIMATION 47
2.5 ASSUMPTIONS 47
2.6 LIMITATIONS 47
2.6.1 METHODOLOGY-RELATED LIMITATIONS 47
2.6.2 SCOPE-RELATED LIMITATIONS 47
2.7 RISK ASSESSMENT 48
3 EXECUTIVE SUMMARY 49
4 PREMIUM INSIGHTS 53
4.1 SURGICAL ROBOTS MARKET OVERVIEW 53
4.2 ASIA PACIFIC: SURGICAL ROBOTS MARKET, BY OFFERING AND COUNTRY (2023) 54
4.3 SURGICAL ROBOTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
4.4 SURGICAL ROBOTS MARKET, BY REGION (2022−2029) 56
4.5 SURGICAL ROBOTS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 56
 
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
5.2.1 DRIVERS 58
5.2.1.1 Advantages of robot-assisted surgery 58
5.2.1.2 Technological advancements 58
5.2.1.3 Improving reimbursement scenario 59
5.2.1.4 Increasing adoption of surgical robots 60
5.2.1.5 Increasing funding for medical robot research 60
5.2.2 RESTRAINTS 61
5.2.2.1 High cost of robotic systems 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 Increasing penetration of surgical robots in ASCs 61
5.2.3.2 Growth opportunities in emerging markets 62
5.2.4 CHALLENGES 63
5.2.4.1 Surgical errors 63
5.3 INDUSTRY TRENDS 64
5.3.1 RISING NUMBER OF MINIMALLY INVASIVE SURGERIES USING SURGICAL ROBOTS 64
5.3.2 TELEPRESENCE AND REMOTE SURGERY 65
5.3.3 EMERGENCE OF SURGICAL NAVIGATION AND IMAGING TECHNOLOGIES 65
5.3.4 REGIONAL OVERVIEW OF ROBOTIC SURGICAL PROCEDURES 65
5.3.5 REGIONAL OVERVIEW OF COMMONLY USED SURGICAL ROBOTIC SYSTEMS, 2020–2023 66
5.3.6 REGIONAL OVERVIEW OF PATIENT PREFERENCE FOR SURGICAL ROBOTIC SYSTEMS 66
5.4 ECOSYSTEM ANALYSIS 67
5.5 SUPPLY CHAIN ANALYSIS 69
5.6 VALUE CHAIN ANALYSIS 70
5.7 TECHNOLOGY ANALYSIS 71
5.7.1 KEY TECHNOLOGIES 71
5.7.1.1 Robotic arms and instruments 71
5.7.1.2 Artificial Intelligence (AI) and Machine Learning (ML) 71
5.7.1.3 Telepresence 72
5.7.1.4 5G Technology 72
5.7.2 COMPLEMENTARY TECHNOLOGIES 72
5.7.2.1 Augmented Reality (AR) and Virtual Reality (VR) 72
5.7.2.2 3D Printing 72
5.8 PORTER’S FIVE FORCES ANALYSIS 73
5.8.1 THREAT OF NEW ENTRANTS 74
5.8.2 THREAT OF SUBSTITUTES 74
5.8.3 BARGAINING POWER OF SUPPLIERS 74
5.8.4 BARGAINING POWER OF BUYERS 74
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 74
5.9 KEY STAKEHOLDERS & BUYING CRITERIA 75
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 76
5.9.2 BUYING CRITERIA 76
5.10 REGULATORY LANDSCAPE 77
5.10.1 NORTH AMERICA 77
5.10.1.1 US 77
5.10.2 EUROPE 78
5.10.3 ASIA PACIFIC 78
5.10.3.1 Japan 78
5.10.3.2 China 79
5.10.3.3 India 80
5.10.4 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION 80
5.11 PATENT ANALYSIS 81
5.11.1 PATENT PUBLICATION TRENDS FOR SURGICAL ROBOTS 81
5.12 TRADE ANALYSIS 84
5.12.1 IMPORT ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL & SURGICAL SCIENCES 84
5.12.2 EXPORT ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL & SURGICAL SCIENCES 85
5.13 PRICING ANALYSIS 85
5.13.1 AVERAGE SELLING PRICE, BY KEY PLAYER 85
5.13.2 AVERAGE SELLING PRICE TREND, BY REGION 86
5.14 REIMBURSEMENT ANALYSIS 86
5.15 KEY CONFERENCES & EVENTS, 2024–2025 88
5.16 UNMET NEEDS AND END-USER EXPECTATIONS 89
5.16.1 UNMET NEEDS 89
5.16.2 END-USER EXPECTATIONS IN SURGICAL ROBOTS MARKET 90
5.17 ADJACENT MARKET ANALYSIS 91
5.18 INVESTMENT & FUNDING SCENARIO 91
5.19 CASE STUDIES 92
5.19.1 REVOLUTIONISING FUTURE OF SURGERY WITH HIGH-PRECISION ROBOTS 92
5.19.2 HUNJAN HOSPITAL DEPLOYS ORTHOPEDIC SURGICAL ROBOT FOR KNEE REPLACEMENT SURGERY 92
5.19.3 BIONAUT LABS CREATES REMOTE-CONTROLLED MICRO-ROBOTS TO TARGET BRAIN DISEASES 93
5.20 IMPACT OF GENERATIVE AI ON SURGICAL ROBOTS MARKET 93
 
6 SURGICAL ROBOTS MARKET, BY OFFERING 94
6.1 INTRODUCTION 95
6.2 INSTRUMENTS & ACCESSORIES 96
6.2.1 NEED FOR RECURRENT PURCHASE OF INSTRUMENTS & ACCESSORIES TO DRIVE MARKET GROWTH 96
6.3 ROBOTIC SYSTEMS 98
6.3.1 LAPAROSCOPIC ROBOTIC SYSTEMS 101
6.3.1.1 Growing popularity of laparoscopic robotic surgeries to drive market 101
6.3.2 ORTHOPEDIC ROBOTIC SYSTEMS 103
6.3.2.1 Rising number of market players offering orthopedic robots to support growth 103
6.3.3 NEUROSURGICAL ROBOTIC SYSTEMS 106
6.3.3.1 Reproducibility and precision to drive uptake 106
6.3.4 OTHER ROBOTIC SYSTEMS 108
6.4 SERVICES 110
6.4.1 ONGOING NEED FOR SERVICES TO PROPEL MARKET 110
7 SURGICAL ROBOTS MARKET, BY APPLICATION 112
7.1 INTRODUCTION 113
7.2 GENERAL SURGERY 114
7.2.1 GROWING PREFERENCE FOR ROBOT-ASSISTED GENERAL SURGICAL PROCEDURES TO DRIVE MARKET GROWTH 114
7.3 GYNECOLOGICAL SURGERY 116
7.3.1 RISING NUMBER OF HYSTERECTOMIES TO INCREASE DEMAND FOR SURGICAL ROBOTS 116
7.4 ORTHOPEDIC SURGERY 118
7.4.1 GROWING PREFERENCE FOR KNEE RECONSTRUCTION PROCEDURES TO SUPPORT GROWTH 118
7.5 UROLOGICAL SURGERY 120
7.5.1 GROWING PREVALENCE OF UROLOGICAL DISEASES TO FUEL DEMAND FOR SURGICAL ROBOTS 120
7.6 NEUROSURGERY 122
7.6.1 INCREASING USE OF ROBOTIC TECHNOLOGIES IN NEUROSURGICAL PROCEDURES TO DRIVE MARKET 122
7.7 MICROSURGERY 124
7.7.1 RISING INTERSECTION OF MINIMALLY INVASIVE SURGERY AND SURGICAL ROBOTS TO SUPPORT GROWTH 124
7.8 OTOLOGICAL SURGERY 126
7.8.1 RISING PREVALENCE OF EAR-RELATED DISORDERS 126
7.9 OTHER APPLICATIONS 128
 
8 SURGICAL ROBOTS MARKET, BY END USER 131
8.1 INTRODUCTION 132
8.2 HOSPITALS & CLINICS 133
8.2.1 INCREASING ROBOTIC-ASSISTED SURGERIES TO PROPEL MARKET GROWTH 133
8.3 AMBULATORY SURGERY CENTERS 136
8.3.1 GROWING PATIENT PREFERENCE FOR AMBULATORY CENTERS DUE TO COST-EFFECTIVE TREATMENTS TO DRIVE GROWTH 136
9 SURGICAL ROBOTS MARKET, BY REGION 139
9.1 INTRODUCTION 140
9.2 NORTH AMERICA 142
9.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK 142
9.2.2 US 147
9.2.2.1 US to dominate North American surgical robots market 147
9.2.3 CANADA 151
9.2.3.1 Increased adoption of surgical robots to drive market 151
9.3 EUROPE 154
9.3.1 EUROPE: MACROECONOMIC OUTLOOK 154
9.3.2 GERMANY 159
9.3.2.1 Germany to dominate European surgical robots market 159
9.3.3 UK 163
9.3.3.1 Rising investments to support adoption of surgical robots to aid market 163
9.3.4 FRANCE 166
9.3.4.1 Favorable investments and growing demand for surgical robotic systems to boost growth 166
9.3.5 SPAIN 170
9.3.5.1 Increasing number of robotic-assisted surgical procedures and initiatives to fuel growth 170
9.3.6 ITALY 173
9.3.6.1 Increasing number of robotic surgical procedures to propel market 173
9.3.7 REST OF EUROPE 177
9.4 ASIA PACIFIC 180
9.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK 180
9.4.2 JAPAN 185
9.4.2.1 Japan to dominate APAC market 185
9.4.3 CHINA 189
9.4.3.1 Increasing initiatives from domestic players to boost market 189
9.4.4 INDIA 193
9.4.4.1 Developments in healthcare infrastructure in India to support market growth 193
 
9.4.5 AUSTRALIA 197
9.4.5.1 Increasing implementation and development of surgical robotic training programs in Australia to boost market 197
9.4.6 SOUTH KOREA 200
9.4.6.1 Increasing installation of surgical robots to ensure market growth 200
9.4.7 REST OF ASIA PACIFIC 203
9.5 LATIN AMERICA 207
9.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK 207
9.5.2 BRAZIL 211
9.5.2.1 Rising incidence of target diseases and growing healthcare expenditure to drive market 211
9.5.3 MEXICO 215
9.5.3.1 Growing emphasis on surgical robotics to support market growth 215
9.5.4 REST OF LATIN AMERICA 218
9.6 MIDDLE EAST & AFRICA 221
9.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 222
9.6.2 GCC COUNTRIES 226
9.6.2.1 Robust healthcare industry to drive market 226
9.6.3 REST OF MIDDLE EAST & AFRICA 230
10 COMPETITIVE LANDSCAPE 234
10.1 OVERVIEW 234
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 234
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN SURGICAL ROBOTS MARKET 235
10.3 REVENUE ANALYSIS 236
10.4 MARKET SHARE ANALYSIS 236
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 239
10.5.1 STARS 239
10.5.2 EMERGING LEADERS 239
10.5.3 PERVASIVE PLAYERS 240
10.5.4 PARTICIPANTS 240
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 241
10.5.5.1 Company footprint 241
10.5.5.2 Offering footprint 242
10.5.5.3 Application footprint 243
10.5.5.4 End-user footprint 244
10.5.5.5 Region footprint 245
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 246
10.6.1 PROGRESSIVE COMPANIES 246
10.6.2 DYNAMIC COMPANIES 246
10.6.3 STARTING BLOCKS 246
 
10.6.4 RESPONSIVE COMPANIES 246
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 248
10.7 VALUATION & FINANCIAL METRICS 249
10.7.1 FINANCIAL METRICS 249
10.7.2 COMPANY VALUATION 249
10.8 BRAND/PRODUCT COMPARISON 250
10.9 COMPETITIVE SCENARIO 251
10.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS 251
10.9.2 DEALS 252
10.9.3 EXPANSIONS 253
10.9.4 OTHER DEVELOPMENTS 253
11 COMPANY PROFILES 254
11.1 KEY PLAYERS 254
11.1.1 INTUITIVE SURGICAL 254
11.1.1.1 Business overview 254
11.1.1.2 Products & services offered 255
11.1.1.3 Recent developments 256
11.1.1.3.1 Product approvals 256
11.1.1.3.2 Deals 257
11.1.1.4 MnM view 257
11.1.1.4.1 Right to win 257
11.1.1.4.2 Strategic choices 257
11.1.1.4.3 Weaknesses & competitive threats 257
11.1.2 STRYKER 258
11.1.2.1 Business overview 258
11.1.2.2 Products offered 259
11.1.2.3 Recent developments 260
11.1.2.3.1 Product launches 260
11.1.2.3.2 Deals 260
11.1.2.3.3 Expansions 261
11.1.2.4 MnM view 261
11.1.2.4.1 Right to win 261
11.1.2.4.2 Strategic choices 261
11.1.2.4.3 Weaknesses & competitive threats 261
11.1.3 MEDTRONIC 262
11.1.3.1 Business overview 262
11.1.3.2 Products offered 263
11.1.3.3 Recent developments 264
11.1.3.3.1 Product approvals 264
11.1.3.3.2 Deals 264
11.1.3.3.3 Expansions 265
11.1.3.4 MnM view 265
11.1.3.4.1 Right to win 265
11.1.3.4.2 Strategic choices 265
11.1.3.4.3 Weaknesses & competitive threats 265
11.1.4 SMITH+NEPHEW 266
11.1.4.1 Business overview 266
11.1.4.2 Products offered 267
11.1.4.3 Recent developments 268
11.1.4.3.1 Product & service launches and enhancements 268
11.1.4.4 MnM view 268
11.1.4.4.1 Right to win 268
11.1.4.4.2 Strategic choices 268
11.1.4.4.3 Weaknesses & competitive threats 268
11.1.5 ZIMMER BIOMET 269
11.1.5.1 Business overview 269
11.1.5.2 Products offered 270
11.1.5.3 Recent developments 271
11.1.5.3.1 Product approvals 271
11.1.5.3.2 Deals 271
11.1.5.3.3 Other developments 271
11.1.5.4 MnM view 272
11.1.5.4.1 Right to win 272
11.1.5.4.2 Strategic choices 272
11.1.5.4.3 Weaknesses & competitive threats 272
11.1.6 ASENSUS SURGICAL INC. 273
11.1.6.1 Business overview 273
11.1.6.2 Products offered 274
11.1.6.3 Recent developments 275
11.1.6.3.1 Product approvals 275
11.1.6.3.2 Deals 275
11.1.7 SIEMENS HEALTHINEERS AG 277
11.1.7.1 Business overview 277
11.1.7.2 Products offered 278
11.1.7.3 Recent developments 279
11.1.7.3.1 Deals 279
11.1.8 RENISHAW PLC 280
11.1.8.1 Business overview 280
11.1.8.2 Products offered 281
11.1.8.3 Recent developments 282
11.1.8.3.1 Product approvals 282
 
11.1.9 CMR SURGICAL 283
11.1.9.1 Business overview 283
11.1.9.2 Products offered 283
11.1.9.3 Recent developments 284
11.1.9.3.1 Deals 284
11.1.10 THINK SURGICAL INC. 285
11.1.10.1 Business overview 285
11.1.10.2 Products offered 285
11.1.10.3 Recent developments 286
11.1.10.3.1 Product approvals 286
11.1.10.3.2 Deals 286
11.1.11 CORIN GROUP 288
11.1.11.1 Business overview 288
11.1.11.2 Products offered 288
11.1.11.3 Recent developments 289
11.1.11.3.1 Product launches & approvals 289
11.1.12 MICROSURE 290
11.1.12.1 Business overview 290
11.1.12.2 Products offered 290
11.1.12.3 Recent developments 290
11.1.12.3.1 Other developments 290
11.1.13 TITAN MEDICAL INC. 291
11.1.13.1 Business overview 291
11.1.13.2 Products offered 292
11.1.13.3 Recent developments 292
11.1.13.3.1 Deals 292
11.1.13.3.2 Other developments 293
11.1.14 AVATERAMEDICAL GMBH (A SUBSIDIARY OF AVATERAMEDICAL N.V.) 294
11.1.14.1 Business overview 294
11.1.14.2 Products offered 294
11.1.15 MEDICAL MICROINSTRUMENTS 295
11.1.15.1 Business overview 295
11.1.15.2 Products offered 295
11.1.15.3 Recent developments 295
11.1.15.3.1 Product approvals 295
11.1.15.3.2 Deals 296
11.1.15.3.3 Other developments 296
 
11.1.16 MEDICAROID CORPORATION 297
11.1.16.1 Business overview 297
11.1.16.2 Products offered 297
11.1.16.3 Recent developments 298
11.1.16.3.1 Product approvals 298
11.1.16.3.2 Deals 298
11.1.17 BRAINLAB AG 299
11.1.17.1 Business overview 299
11.1.17.2 Products offered 299
11.1.17.3 Recent developments 300
11.1.17.3.1 Product approvals 300
11.1.17.3.2 Deals 300
11.1.18 ECENTIAL ROBOTICS 301
11.1.18.1 Business overview 301
11.1.18.2 Products offered 301
11.1.18.3 Recent developments 302
11.1.18.3.1 Product approvals 302
11.1.18.3.2 Deals 302
11.1.19 GLOBUS MEDICAL, INC. 303
11.1.19.1 Business overview 303
11.1.19.2 Products offered 304
11.1.20 JOHNSON & JOHNSON 305
11.1.20.1 Business overview 305
11.1.20.2 Products offered 306
11.1.20.3 Recent developments 307
11.1.20.3.1 Product approvals 307
11.2 OTHER PLAYERS 308
11.2.1 MOMENTIS INNOVATIVE SURGERY LTD. 308
11.2.2 TINAVI MEDICAL TECHNOLOGIES CO LTD 309
11.2.3 DISTALMOTION 310
11.2.4 MONTERIS 310
11.2.5 NOVUS SAĞLIK ÜRÜNLERI AR-GE DANIŞMANLIK 311
12 APPENDIX 312
12.1 DISCUSSION GUIDE 312
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 316
12.3 CUSTOMIZATION OPTIONS 318
12.4 RELATED REPORTS 318
12.5 AUTHOR DETAILS 319